Business Alignment Public Company Limited Proposes Cash Dividend for the Year Ended 31 December, 2021, Payable on 5 May, 2022
February 23, 2022 at 07:42 am EST
Share
Business Alignment Public Company Limited at its board meeting held on 23 February, 2022, approved to propose to Annual General Meeting of Shareholders to consider and approve the dividend payment to the shareholders from the operating results of January 1, 2021 to December 31, 2021 as: distribute dividend in the form of cash at the rate of THB 0.42777777750 per share, or equivalent to not exceeding THB 171,111,111. In this regard, after the calculation of dividends in the form of cash which the shareholders will be entitled to receive in Thai baht with 2 decimal places in Satang unit. In calculating 2 decimal places, if any fraction is more than or equivalent to THB 0.005, such fraction will be rounded up. If any fraction is less than THB 0.005, such fraction will be rounded down. In this regard, the Company has set the date to determine the dividends (Record Date) on 22 April, 2022 and the dividend payment date is on 5 May, 2022. However, the right to receive dividend is uncertain until the approval of the 2022 Annual General Meeting of Shareholders is granted.
Business Alignment Public Company Limited is a Thailand-based company, which is engaged in distribution and installation of medical equipment for cancer treatment through radiotherapy. The Company is engaged in sales of medical equipment including installation and related activities, such as the construction of building for locating medical equipment, repair, and maintenance, and increasing the efficiency of medical equipment. The Company operates through two segments: Sales of medical equipment and Hospital operations. The Sales of medical equipment segment includes installation and related activities such as the construction of building for locating medical equipment, repair, and maintenance, and increasing efficiency of medical equipment. The Hospital operations segment is specialized in cancer treatment. Its customers are university-affiliated hospitals, cancer hospitals, Ministry of Public Health, other government hospitals, healthcare agencies, and private hospitals.